The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs Number of planned job losses
Announcement Date
17 February 2009
Employment effect (start)
Foreseen end date
31 December 2009
Description
Pliva-Lachema, one of the leading Czech pharmaceutical producers, has announced that it plans to cut 100 jobs out of 650 by the end of 2009. The workforce reduction is due to a recent acquisition of the mother American Group Barr Pharmaceuticals by Israeli company Teva Pharmaceutical occurred in December 2008. The company said it would close its production of solid pharmaceutical forms and restrict research activities.
Sources
17 February 2009: Hospodárske noviny
Citation
Eurofound (2009), Pliva Lachema, Merger/Acquisition in Czechia, factsheet number 68206, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/68206.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
